On November 29, 2012, ProUroCare Medical Inc. amended the maturity date of its $900,000 promissory note with Crown Bank. The maturity date was changed to December 31, 2012. The outstanding principal balance due on the note is $500,000. There were no other changes made in the terms of the Crown Loan. The Crown Loan remains secured by all company assets and continues to be guaranteed by James L. Davis, a director of the company and William S. Reiling.

The company also announced that current director Dr. Michael Chambers, JD, Ph.D., has been named Chairman of its Board of Directors. Dr. Chambers is an experienced businessman, entrepreneur and attorney. Dr. Chambers currently serves as President and CEO of Swift Biotechnology. Dr. Chambers also serves on the corporate boards of InqBio Systems, Gene Capture and BioAlabama. Dr. Chambers assumes the Chairmanship role from Rick Carlson, company's CEO, who will continue to serve as CEO and Director.